A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head
Clinical trial NCT07471880 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07471880
- Sponsor
- ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-24
- Primary completion
- 2026-10-10
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.